Breast Cancer Clinical Trials

Find clinical trials for breast cancer. Search for breast cancer clinical trials in different cities and states across the United States.

Filter

Filter results

Results: 1,041

BT8009Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Recruiting

PHASE1

PHASE2

Sponsor:

BicycleTx Limited

Location:

Denver CO, Ocala FL, Orlando FL, Lafayette INshow 10 more

Code:

NCT04561362

Conditions

Urinary Bladder Neoplasm

Triple Negative Breast Neoplasms

Hormone Receptor Positive, HER2-negative Neoplasms

Hormone Receptor Positive, HER2-low Neoplasms

Breast Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BT8009

Pembrolizumab

PF-08046054A Study of SGN-PDL1V in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Seagen Inc.

Location:

Birmingham AL, Sacramento CA, Iowa City IA, Detroit MIshow 8 more

Code:

NCT05208762

Conditions

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of the Head and Neck

Esophageal Squamous Cell Carcinoma

Ovarian Neoplasms

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-08046054

pembrolizumab

MRI AssessmentQuantitative MRI Assessment of Breast Cancer Therapy Response

Recruiting

Sponsor:

OHSU Knight Cancer Institute

Location:

Iowa City IA, Portland OR, Seattle WA

Code:

NCT05704062

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Diffusion Weighted Imaging

Dynamic Contrast-Enhanced Magnetic Resonance Imaging

CX-4945Dose-escalation Study of Oral CX-4945

Recruiting

PHASE1

Sponsor:

Cylene Pharmaceuticals

Location:

Scottsdale AZ, Fort Collins CO, Loveland CO, Houston TX

Code:

NCT00891280

Conditions

Advanced Solid Tumors

Breast Cancer

Inflammatory Breast Cancer

Castleman's Disease

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CX-4945 oral formulation

Ribociclib, Tucatinib, TrastuzumabRibociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

Jonsson Comprehensive Cancer Center

Location:

Los Angeles CA

Code:

NCT05319873

Conditions

Anatomic Stage II Breast Cancer AJCC v8

Anatomic Stage IIA Breast Cancer AJCC v8

Anatomic Stage IIB Breast Cancer AJCC v8

Anatomic Stage III Breast Cancer AJCC v8

Anatomic Stage IIIA Breast Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Docetaxel

Fulvestrant

Pertuzumab

Quality-of-Life Assessment

Observational StudyStudy of Screening Brain MRIs in Stage IV Breast Cancer

Recruiting

Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Location:

Clearwater FL, Tampa FL

Code:

NCT05115474

Conditions

Triple Negative Breast Cancer

HER2-positive Breast Cancer

Hormone Receptor-positive Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Magnetic Resonance Imaging

SAcituzumab Govitecan & TrastuzumabA Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)

Recruiting

PHASE2

Sponsor:

Adrienne G. Waks

Location:

Boston MA, South Weymouth MA, Nashville TN

Code:

NCT06100874

Conditions

Her 2 Positive Breast Cancer

Breast Cancer Female

Breast Cancer Metastatic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sacituzumab Govitecan

Trastuzumab

Trastuzumab and Hyaluronidase-oysk

NX-1607A Study of NX-1607 in Adults With Advanced Malignancies

Recruiting

PHASE1

Sponsor:

Nurix Therapeutics, Inc.

Location:

Los Angeles CA, San Francisco CA, Aurora CO, Chicago ILshow 5 more

Code:

NCT05107674

Conditions

Ovarian Cancer, Epithelial

Gastric Cancer

GastroEsophageal Junction (GEJ) Cancer

Head and Neck Squamous Cell Carcinoma

Metastatic or Unresectable Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NX-1607

Paclitaxel

Focused Ultrasound & GemcitabineFocused Ultrasound and Gemcitabine in Breast Cancer

Recruiting

PHASE1

Sponsor:

Patrick Dillon, MD

Location:

Charlottesville VA

Code:

NCT04796220

Conditions

Breast Cancer

Breast Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Gemcitabine

Focused Ultrasound

Gemcitabine and Focused Ultrasound

EP0062Phase 1/2 Study to Evaluate Vosilasarm (EP0062) as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

Recruiting

PHASE1

PHASE2

Sponsor:

Ellipses Pharma

Location:

New Haven CT, Tampa FL, Boston MA, Detroit MIshow 3 more

Code:

NCT05573126

Conditions

Hormone Receptor-positive Breast Cancer

Hormone Receptor Positive HER-2 Negative Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Vosilasarm

Elacestrant

Everolimus